Hydroxychloroquine Associated With Lower COVID-19 Mortality: Study

“People who received hydroxychloroquine were less likely to die than those who did not, according to a new study.

Just 0.8 percent of patients at a facility in France who received hydroxychloroquine (HCQ) and an antibiotic died, compared to 4.8 percent of patients who did not receive the drug combination, French researchers reported on Nov. 1.

Researchers examined records from 30,423 patients with COVID-19 who were treated at another institution in Marseille, IHU Méditerranée Infection. They included all adults who tested positive for COVID-19 and who were treated in the hospital as an inpatient or an outpatient between March 2, 2020, and Dec. 31, 2021.

Those who received HCQ and AZ were more likely to survive regardless of whether they were inpatients or outpatients.

The biggest effect was recorded in outpatients aged 50 to 89.”

https://x.com/thechiefnerd/status/1720460073221152855

Full Story: https://bit.ly/3QieAlE

@ChiefNerd